IMU imugene limited

18.2%

1.3¢

Why IMU is not a multi-bagger and now will never be, page-89

First 89 Last

Share
Profile

Follow
melburnian

2,965 Posts.

669

12/04/24

11:24

Post #: 73311899
Share

Originally posted by borano: ↑

It's already had it's time in the sun and most, if not all of you were too greedy back back in the 2nd half of 2021 to take the money off the table.
What a lot of you would have done was catching the falling knife, not once and not even twice. Now your hands more than 2 years later have still not healed. I know what I would do if I was like a lot of you. I would grab some vaseline and put it on my hands and the rest would be history.

Dilution has made sure this stock will find it very difficult to climb to the heights of Mt Everest again.

I've been reading this forum for over 6 months now and never heard so much BS in my life .Nothing is happening.

All it (IMU) has been is a meme stock for years. It may never go back to it's previous glory days which most of you did not take advantage of.
Greed is not good most of the time.

The saying goes "YOU WIN SOME BUT YOU LOSE MORE" I am LFAO seriously.

Forget what the company has and what it's doing. Thousands, if not tens of thousands of companies around the world are doing exactly the same thing. Registering patents, research, presentations, conventions etc etc.

Did anyone here know that IMU was once the 2nd biggest biotech market cap company behind CSL once when it was valued at over $3 billion.

It's got me F@#$#$d how this stock can go from high 60 cents to a low of around 4 cents in the span of a couple of years and now it's up 100% in 6 months. Too fricken funny.

10 cents as I write. What a dog stock.

Expand

You could have bought at 4c and sold for 11c.

but you didnt. Many did.

thanks for taking time out from catching falling knives on the dogs you hold anyway. You're not that smart are you.

Last edited by melburnian: 12/04/24

IMU Price at posting: 9.4¢ Sentiment: Buy Disclosure: Held
5 Upvote

0 Great analysis

Reply

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

First 89 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 1.3¢		Change 0.002(18.2%)		Mkt cap ! $97.07M

Open	High	Low	Value	Volume
1.2¢	1.4¢	1.1¢	$625.7K	50.56M

Buyers (Bids)

No.	Vol.	Price($)
20	5795292	1.2¢

Sellers (Offers)

Price($)	Vol.	No.
1.3¢	3258567	9

View Market Depth

No.	Vol.	Price($)
20	5795292	0.012
39	12054746	0.011
123	37475571	0.010
38	20531668	0.009
14	4320747	0.008

Price($)	Vol.	No.
0.013	3258567	9
0.014	11336079	44
0.015	6830166	21
0.016	6274494	28
0.017	7081669	12

Last trade - 16.10pm 27/06/2025 (20 minute delay)

IMU (ASX) Chart

Why IMU is not a multi-bagger and now will never be, page-89

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Why IMU is not a multi-bagger and now will never be, page-89

Top Stories

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

Australia’s gas crisis is here – and dying coal plants aren’t helping

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Boss extends June win streak with boosted Alta Mesa extraction rates

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

'Not possible' to port renewable gas: ACCC takes AGN to court

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News